• For US Healthcare Professionals
  • For Patients and Caregivers
A A A

Resource Center >

My Patient Solutions®
  • For Patients or Caregivers
  • Learn About Our Services
  • Find Patient Assistance
  • Forms & Documents

Resource Center >

My Patient Solutions®
  • ACTEMRA® (tocilizumab)‎
  • ALECENSA® (alectinib)
  • AVASTIN® (bevacizumab)
  • COTELLIC® (cobimetinib)
  • ERIVEDGE® (vismodegib)
  • ESBRIET® (pirfenidone)
  • GAZYVA® (obinutuzumab)
  • HEMLIBRA® (emicizumab-kxwh)
  • HERCEPTIN® (trastuzumab)
  • KADCYLA® (ado-trastuzumab emtansine)
  • LUCENTIS® (ranibizumab injection)
  • OCREVUS® (ocrelizumab)
  • PERJETA® (pertuzumab)
  • PULMOZYME® (dornase alfa) Inhalation Solution
  • RITUXAN® (rituximab)
  • RITUXAN HYCELA® (rituximab/hyaluronidase human)
  • TARCEVA® (erlotinib)
  • TECENTRIQ® (atezolizumab)
  • VENCLEXTA® (venetoclax tablets)
  • XOLAIR® (omalizumab) for subcutaneous use
  • ZELBORAF® (vemurafenib)
  • BIOONCOLOGY
  • RHEUMATOLOGY

Please select a treatment to continue

  • ACTEMRA® (tocilizumab)‎
  • ALECENSA® (alectinib)
  • AVASTIN® (bevacizumab)
  • COTELLIC® (cobimetinib)
  • ERIVEDGE® (vismodegib)
  • ESBRIET® (pirfenidone)
  • GAZYVA® (obinutuzumab)
  • HEMLIBRA® (emicizumab-kxwh)
  • HERCEPTIN® (trastuzumab)
  • KADCYLA® (ado-trastuzumab emtansine)
  • LUCENTIS® (ranibizumab injection)
  • OCREVUS® (ocrelizumab)
  • PERJETA® (pertuzumab)
  • PULMOZYME® (dornase alfa) Inhalation Solution
  • RITUXAN® (rituximab)
  • RITUXAN HYCELA® (rituximab/hyaluronidase human)
  • TARCEVA® (erlotinib)
  • TECENTRIQ® (atezolizumab)
  • VENCLEXTA® (venetoclax tablets)
  • XOLAIR® (omalizumab) for subcutaneous use
  • ZELBORAF® (vemurafenib)
  • Or Select

  • BIOONCOLOGY
  • RHEUMATOLOGY

Please select a treatment to continue

Select a disease state for Rituxan® (rituximab)

  • RITUXAN® (rituximab) for Rheumatoid Arthritis (RA)
  • RITUXAN® (rituximab) for Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
  • RITUXAN® (rituximab) for BioOncology
  • RITUXAN® (rituximab) for Pemphigus Vulgaris (PV)
There were no results for your search.
2019

Contact Us   Site Map  Privacy Policy  Terms & Conditions 

©[YEAR] Genentech USA, Inc.  All rights reserved.  This site is intended for US residents only.

The Access Solutions logo is a registered trademark of Genentech, Inc.

hcp_m_icon_pat_footer Patient Assistance Tool >

For assistance, call (866) 422‑2377

6 a.m.–5 p.m. PT, Monday through Friday

Patient Assistance Tool >
Find the right assistance option for your patients 

Link to Third Party Site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Cancel OK

Link to Healthcare Professionals Site

The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.

Cancel OK

Cancel

Your email has been sent!

Thanks for sharing this page.